ISTAART

"A caregiver has to learn the skill of how to support themselves, because if they can't look after their own well-being, if a caregiver is not well, they will not be able to look after the person with dementia." Association-funded researcher, #AAICNeuro "One to Watch" Awardee and @ISTAART member Wambūi Karanja spoke to @NPR about the importance of caregiver health, her family's journey with dementia and what it's like facing dementia in Kenya. n.pr/40YKTMb

What an amazing week spent sharing ideas and scientific breakthroughs, making new connections and reuniting with friends at #AAIC25! See you next year in London, United Kingdom 🇬🇧, for as we continue to move dementia science and clinical practice forward!

Thank you to the more than 11,700 researchers, clinicians and dementia professionals who joined us in Toronto and online for #AAIC25! Together, you advanced science and clinical practice and have given hope to all those living with Alzheimer’s and all other dementia.

🏆 Donna M. Wilcock, Ph.D., is the recipient of the 2025 Bill Thies Award for Distinguished Service to ISTAART. This award recognizes an @ISTAART member who has provided continued and outstanding service to the ISTAART community. During her tenure on the ISTAART Advisory Council, Dr. Wilcock championed the support and development of the next generation of dementia scientists through ISTAART’s initiatives. Her steadfast dedication to mentoring and advancing junior scientists has continued into her current role as the editor-in-chief of @alzdemjournals. @IndianaUniv @IUMedSchool @IUStark_Neuro #AAIC25

Congratulations to our #AAIC25 @ISTAART student and postdoctural poster competition winners! 🔬 @FernandaBAragao 🔬 @kangmspeter 🔬 @lidia_vaque 🔬 Tae Yeon Kim 🔬 Lara Huyghe 🔬 Eden Mancor

Exclusive offer for #AAIC25 attendees: Join @ISTAART as a new member during AAIC to receive 10% off membership dues! Stop by the Alzheimer's Association booth in the Exhibit Hall or visit alz.org/ISTAART to join.

For Luis Medina, Ph.D., clinical neuropsychologist, associate processor at the University of Houston and one of the #BrightMinds in Alzheimer’s and Dementia research, membership in @ISTAART has been instrumental for him in developing a circle of colleagues and collaborators within the field. “ISTAART was what really introduced me to the Alzheimer's Association and to AAIC as a volunteer more than 10 years ago. … It has been extremely rewarding in my career trajectory because it connected me across the globe with fantastic people and fantastic mentors — people who've become collaborators and dear colleagues of mine.” Dr. Medina, along with the members of ISTAART representing more than 120 countries, share a common goal: to pursue knowledge, collaborations and breakthroughs in order to find more effective ways to detect, treat and prevent Alzheimer's and other dementias. “It's been extremely rewarding to find that community and that network. This work really is multidisciplinary, cross-disciplinary, interdisciplinary, and we need each other in order to find a cure.” Are you a dementia professional? Learn more about ISTAART and join today: istaart.alz.org/ #AAIC25

How #AAIC25 attendees can get instructions for obtaining the CME and CE credits ⬇️ 🍁 In-person attendees: Visit the registration desk. 💻 Virtual attendees: Go to the Continuing Education tab on the online platform. Credits are free for @ISTAART members and $100 for non-ISTAART members.

BREAKING: Results from U.S. POINTER, reported today at #AAIC25, show that lifestyle interventions that simultaneously target risk factors protect cognitive function in older adults at increased risk for cognitive decline and dementia — protecting cognition from normal age-related decline for up to two years. bit.ly/USPointerRelease

Breaking from #AAIC25: U.S. POINTER study shows two-year structured lifestyle intervention improves cognition in older adults at risk of cognitive decline and dementia. Takeaways: ➡️ Both a structured and a self-guided intervention improved cognition, with the structured group improving even more This means participants in the structured group performed at a level comparable to adults 1 to 2 years younger in age. ➡️ Cognitive benefits were consistent across age, sex, ethnicity, heart health status and APOE e4 genotype.

U.S. POINTER is the first large-scale, randomized controlled clinical trial to demonstrate that lifestyle intervention targeting multiple risk factors can protect cognitive function in diverse populations in communities across the United States, according to data reported today from #AAIC25. People with cognitive decline and dementia often have a variety of damaging changes in their brain. This means effective treatment will likely require a multi-pronged or combination strategy to address multiple disease mechanisms. U.S. POINTER provides a strong foundation for such combination approaches.

🏆 Christos Davatzikos, Ph.D., is the 2025 recipient of the de Leon Prize In Neuroimaging - Senior Scientist. Dr. Davatzikos oversees a diverse research program ranging from basic problems of imaging pattern analysis and machine learning, to a variety of clinical studies of aging and Alzheimer’s disease, neuropsychiatric disorders and brain cancer. @Penn #AAIC25

🏆 Hironobu Endonzmeier, M.D., Ph.D. is a 2025 recipient of the de Leon Prize In Neuroimaging - Junior Scientist. Dr. Endonzmeier’s research combines clinical expertise with cutting-edge imaging techniques to advance our understanding of brain disorders. #AAIC25

🏆 Maiko Ono, Ph.D. is a 2025 recipient of the de Leon Prize In Neuroimaging - Junior Scientist. Dr. Ono promotes research on brain activity and brain disease pathology through the multimodal use of PET, MRI and other biological imaging techniques. #AAIC25

🏆 Karly Cody, Ph.D. is the 2025 recipient of the de Leon Prize In Neuroimaging - Trainee. Dr. Cody’s current research implements neuroimaging and fluid biomarkers to characterize pathological and clinical trajectories in aging and Alzheimer’s disease. @Stanford @Stanford_Neuro #AAIC25